Cytometric Immunodiagnostics of Latent Tuberculosis Infection (LTBI)
NCT04673227 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2020-12-17
Summary
TB-reactive immune cells will be tested in a multiparametric flow cytometry to distinguish an immune response for antigens of Mycobacterium spp. in TB disease/latent infection or a reaction after BCG vaccine.
Conditions
- LTBI
- BCG Vaccination Reaction
- TB
Interventions
- DIAGNOSTIC_TEST
-
Blood draw
Blood draw and the analysis of blood in laboratory
Sponsors & Collaborators
-
Thomayer University Hospital
lead OTHER -
Charles University, Czech Republic
collaborator OTHER
Eligibility
- Min Age
- 4 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-02
- Primary Completion
- 2020-05-26
- Completion
- 2022-12-26
Countries
- Czechia
Study Locations
More Related Trials
-
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy
NCT00811343 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
NCT05592223 ·Status: COMPLETED ·Phase: PHASE1
-
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
NCT07170735 ·Status: RECRUITING
-
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
NCT06580639 ·Status: RECRUITING
-
Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation
NCT04830462 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-γ Assay
NCT00962793 ·Status: COMPLETED
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
NCT01119521 ·Status: COMPLETED ·Phase: PHASE1
-
Immunological Biomarkers in Tuberculosis Management
NCT04271397 ·Status: RECRUITING ·Phase: NA
-
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
NCT06526689 ·Status: RECRUITING
-
Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
NCT00767975 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Challenge Study of BCG in Healthy Volunteers
NCT02088892 ·Status: COMPLETED ·Phase: NA
-
Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment
NCT00517231 ·Status: WITHDRAWN
-
Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection
NCT03312647 ·Status: UNKNOWN
-
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
NCT06019052 ·Status: NOT_YET_RECRUITING
-
A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG
NCT01242475 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the QuantiFERON-TB Test.
NCT02142894 ·Status: COMPLETED
-
Latent Tuberculosis Infection in Korean Health Care Workers
NCT03010111 ·Status: UNKNOWN ·Phase: NA
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
NCT00456469 ·Status: UNKNOWN
-
Latent Tuberculosis Infection in Cancer Patients
NCT00507754 ·Status: COMPLETED
-
Identifcation of Biomarkers for Active Pulmonary Tuberculosis
NCT04490746 ·Status: UNKNOWN
-
Evaluation of the QuantiFERON-TB Test.
NCT02253537 ·Status: COMPLETED
-
Potential Role of Microbiome in Tuberculosis
NCT04985994 ·Status: COMPLETED